Insecticides (India) Limited (INSECTICID) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Insecticides (India) Limited ₹425, price ₹569, upside -25.2%, quality 56 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Insecticides (India) Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 2, 2026.
How to read this chart
60‑month range ₹383.70 – ₹1,069 · fair‑value band ₹331.14 – ₹770.18 · the ₹568.70 price screens above the ₹425.38 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 2, 2026.
Follow Insecticides (India) in your weekly email
Every Wednesday you see whether Insecticides (India) is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Insecticides (India) Limited manufactures and sells agrochemicals, pesticides, and technical products in India and internationally. It offers crop protection and nutrition products, including fungicides, insecticides, herbicides, biologicals, and plant growth regulators.
Show more
Insecticides (India) Limited manufactures and sells agrochemicals, pesticides, and technical products in India and internationally. It offers crop protection and nutrition products, including fungicides, insecticides, herbicides, biologicals, and plant growth regulators. The company sells its products through a network of distributors, retailers, and dealers under the Tractor brand. The company was incorporated in 1996 and is based in Delhi, India.
Stock analysis
Insecticides (India) Limited (INSECTICID) currently trades at ₹568.70, while our model-based Fair Value estimate is ₹425.38, 25.2% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ₹814.49 per share, and 11 of the 25 models we run sit above the ₹568.70 price.
Bear case: the Growth DCF group reads lowest at ₹81.80, and 14 of the 25 models stay below the price. Evidence for this calculation is high.
Scenario range: ₹331.14 (bear) to ₹770.18 (bull), the price of ₹568.70 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 56/100 (solid quality), in the Basic Materials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Insecticides (India) Limited reported revenue of ₹21.4B in FY2026 versus ₹15.0B in FY2022, a compound +9.3%/yr. Reported net income was ₹1.4B in FY2026, compounding +6.7%/yr from FY2022.
Key figures
Market cap ₹17.0B (≈ $176M) · P/E ratio 13.2 · P/S ratio 0.86 · EPS (TTM) ₹43.02 · Dividend yield 0.4% · Net margin 6.5% · Return on equity 12.1% · Return on assets (EBIT) 11.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 26% below its 52-week high and 8% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at 17% fair-value upside, at −25%, INSECTICID screens richer than that median.
Fair Value models
Bear ₹331.14Fair Value ₹425.38Bull ₹770.18
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (₹20.79 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+7.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.7%
Start year 2021 (pandemic). Over 10 years: +9.0% a year
Revenue growth 21 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.4%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+9.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+9.0%
Dividend (yield on the price)0.4%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.9.0% vs 9.3%, steady
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.9% → 9%
Compare Insecticides (India) Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Agricultural Inputs · 170 stocks
Beats the industry median on 9/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score56 · Above median
Fair Value upside−25.2% · Below median
Profitability
Return on equity (TTM)12.1% · Above median
Return on assets6.8% · Above median
Net margin (TTM)6.1% · Above median
Operating margin (TTM)9.5% · Above median
Growth and dividend
Revenue growth−11.5% · Bottom 25%
Dividend yield (TTM)0.4% · Bottom 25%
Balance sheet
Debt / equity0.02× · Below median
Valuation Multiplesvs Agricultural Inputs median · lower = cheaper
P/E (TTM)13.2× · Cheaper than median
P/B1.40× · Pricier than median
P/S (TTM)0.82× · Cheaper than median
EV/EBITDA7.2× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 23
FUTURE (revenue growth)0· sector 20
PAST (return on equity)48· sector 25
HEALTH (low debt)99· sector 97
DIVIDEND (yield)7· sector 41
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Insecticides (India) Limited (INSECTICID) overvalued or undervalued?
As of Oct 2, 2026, our model estimates a fair value of ₹425.38 versus a price of ₹568.70, about −25% upside (overvalued).
What is the fair value of INSECTICID?
Our model-based fair value for Insecticides (India) Limited is ₹425.38 (as of Oct 2, 2026), built from audited fundamentals. The current price: ₹568.70.
What is the quality score of INSECTICID?
Insecticides (India) Limited has a Quality Score of 56/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Insecticides (India) Limited (INSECTICID)?
Our model-based price target is the fair value of ₹425.38 (as of Oct 2, 2026) from 25 valuation models. Cautious scenario ₹331.14, optimistic scenario ₹770.18. It is a calculation from audited fundamentals, not an analyst target.
What is the Insecticides (India) Limited stock forecast for 2026?
Our models put fair value at ₹425.38, about −25% upside versus a price of ₹568.70 (overvalued). Cautious scenario ₹331.14, optimistic scenario ₹770.18. The calculation is refreshed regularly with new filings.
What is the revenue of Insecticides (India) Limited (INSECTICID)?
Insecticides (India) Limited reported trailing-twelve-month revenue of about ₹20.7B (latest available figure, as of Oct 2, 2026).
Does Insecticides (India) Limited pay a dividend?
Insecticides (India) Limited currently shows a dividend yield of about 0.35% relative to its recent price (as of Oct 2, 2026).
What is the intrinsic value of Insecticides (India) Limited (INSECTICID)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Insecticides (India) Limited it is ₹425.38 per share (as of Oct 2, 2026), against a price of ₹568.70. It is the blended result of 25 valuation models (cash flow, earnings, asset, dividend).
Is Insecticides (India) Limited stock overvalued or undervalued in 2026?
As of Oct 2, 2026, INSECTICID trades above its calculated fair value: price ₹568.70, fair value ₹425.38, a gap of about −25% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of INSECTICID?
No. The price is what the market pays today (₹568.70); the fair value is what the company's own numbers justify (₹425.38). For Insecticides (India) Limited the two are ₹143.32 per share apart. That gap is exactly why we show both numbers side by side.
How much is Insecticides (India) Limited worth?
The market values Insecticides (India) Limited at about ₹17.0B (market capitalisation, as of Oct 2, 2026). Per share that is ₹568.70; our models calculate a fair value of ₹425.38 per share.
What do the bullish and bearish scenarios say about INSECTICID?
Our models span a range for Insecticides (India) Limited: cautious scenario ₹331.14, base ₹425.38, optimistic ₹770.18 per share (as of Oct 2, 2026, price ₹568.70). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of INSECTICID?
Insecticides (India) Limited trades at a price-to-earnings ratio of 13.2 (as of Oct 2, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹425.38 is built from several models across several years. Other multiples: P/B 1.4, P/S 0.8, EV/EBITDA 7.2.
How solid is the balance sheet of Insecticides (India) Limited (INSECTICID)?
Balance-sheet figures for Insecticides (India) Limited (as of Oct 2, 2026): return on equity 12.1%, debt of 0.02 per unit of equity. They feed the Quality Score of 56/100, which measures business quality independently of the share price.
How far is INSECTICID from its 52-week high?
Insecticides (India) Limited trades at ₹568.70, about 26% below its 52-week high of ₹765.10 and 8% above the low of ₹528.40 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹425.38 is for.
Which stocks are comparable to Insecticides (India) Limited?
From the same area (Basic Materials) we also value Corteva, Inc, Nutrien Ltd, Qinghai Salt Lake Industry Co, CF Industries Holdings, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Insecticides (India) Limited stock attractive at the current price?
The data as of Oct 2, 2026: price ₹568.70, calculated fair value ₹425.38 (−25%), Quality Score 56/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of INSECTICID calculated?
We run Insecticides (India) Limited through 25 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹425.38, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Insecticides (India) Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Insecticides (India) Limited (INSECTICID)?
The closing price on Oct 1, 2026 was ₹568.70. Our model-based fair value is ₹425.38, about −25% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Insecticides (India) Limited right now?
Solid but not exceptional quality (56/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (₹331.14 to ₹770.18) leaves room in how you read the outcome.
Where does the earnings growth of Insecticides (India) Limited (INSECTICID) come from?
Earnings per share at Insecticides (India) Limited grew +10.9 % a year from 2015 to 2026. Broken into its drivers: revenue per share +9.3 %, EBIT margin +3.6 %, tax rate −0.5 %, residual (interest, one-offs) −1.6 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Insecticides (India) Limited
How large is the market capitalisation of Insecticides (India) Limited (INSECTICID)?
The market capitalisation of Insecticides (India) Limited is ₹17.0B (≈ $176M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Insecticides (India) Limited (INSECTICID)?
The price-to-sales ratio of Insecticides (India) Limited is 0.86 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Insecticides (India) Limited (INSECTICID)?
Earnings per share at Insecticides (India) Limited are ₹43.02 (price ÷ EPS = P/E 13.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Insecticides (India) Limited (INSECTICID)?
The dividend yield of Insecticides (India) Limited is 0.4% (payout 4.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Insecticides (India) Limited (INSECTICID)?
The net margin of Insecticides (India) Limited is 6.5% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Insecticides (India) Limited (INSECTICID)?
The return on equity (ROE) of Insecticides (India) Limited is 12.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Insecticides (India) Limited (INSECTICID)?
On an EBIT basis the return on assets of Insecticides (India) Limited is 11.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Insecticides (India) Limited (INSECTICID)?
The operating margin of Insecticides (India) Limited is 9.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Insecticides (India) Limited (INSECTICID)?
Revenue at Insecticides (India) Limited is growing −11.5% versus a year earlier (3y avg +6.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Insecticides (India) Limited (INSECTICID)?
Earnings per share at Insecticides (India) Limited are growing −24.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Insecticides (India) Limited (INSECTICID) generate?
The free cash flow of Insecticides (India) Limited is ₹1.2M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Insecticides (India) Limited (INSECTICID) carry?
The net debt of Insecticides (India) Limited is ₹641M (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Insecticides (India) Limited in the live analysis
One click puts Insecticides (India) Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
